Review




Structured Review

Shanghai Model Organisms Center il 34 em2smoc
(A) <t>Standardized</t> <t>IL-34</t> levels measured in cerebrospinal fluid (CSF; SomaScan) across Y213X genotypes (WT/WT, WT/MUT, MUT/MUT). (B) Standardized IL-34 levels measured in serum (Olink) across Y213X genotypes. (C) Relationship between standardized IL-34 levels and age, shown for CSF (gray) and serum (red). (D) Correlation between serum and CSF IL-34 levels across all subjects. (E) Expected Y213X carrier and homozygote frequencies across populations and continents derived from allele frequency under Hardy–Weinberg equilibrium. (F) IL-34 levels in CSF and serum stratified by sex, dementia status, amyloid status, and tau status. (G) Pearson correlations between IL-34 and CSF Alzheimer’s disease biomarkers (Aβ 42 , pTau181, and total tau), shown for all subjects and after stratification by Y213X carrier status and amyloid status. Error bars denote 95% confidence intervals. Asterisks indicate significance thresholds (∗ p < 0.01, ∗∗ p < 0.001).
Il 34 Em2smoc, supplied by Shanghai Model Organisms Center, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+34+em2smoc/34+em2smoc+il/med_rxiv__64898__2026__02__21__26346696-261-21-23
Average 86 stars, based on 1 article reviews
il 34 em2smoc - by Bioz Stars, 2026-10
86/100 stars

Images

1) Product Images from "Defining and Modeling Human Interleukin-34 Deficiency"

Article Title: Defining and Modeling Human Interleukin-34 Deficiency

Journal: medRxiv

doi: 10.64898/2026.02.21.26346696

(A) Standardized IL-34 levels measured in cerebrospinal fluid (CSF; SomaScan) across Y213X genotypes (WT/WT, WT/MUT, MUT/MUT). (B) Standardized IL-34 levels measured in serum (Olink) across Y213X genotypes. (C) Relationship between standardized IL-34 levels and age, shown for CSF (gray) and serum (red). (D) Correlation between serum and CSF IL-34 levels across all subjects. (E) Expected Y213X carrier and homozygote frequencies across populations and continents derived from allele frequency under Hardy–Weinberg equilibrium. (F) IL-34 levels in CSF and serum stratified by sex, dementia status, amyloid status, and tau status. (G) Pearson correlations between IL-34 and CSF Alzheimer’s disease biomarkers (Aβ 42 , pTau181, and total tau), shown for all subjects and after stratification by Y213X carrier status and amyloid status. Error bars denote 95% confidence intervals. Asterisks indicate significance thresholds (∗ p < 0.01, ∗∗ p < 0.001).
Figure Legend Snippet: (A) Standardized IL-34 levels measured in cerebrospinal fluid (CSF; SomaScan) across Y213X genotypes (WT/WT, WT/MUT, MUT/MUT). (B) Standardized IL-34 levels measured in serum (Olink) across Y213X genotypes. (C) Relationship between standardized IL-34 levels and age, shown for CSF (gray) and serum (red). (D) Correlation between serum and CSF IL-34 levels across all subjects. (E) Expected Y213X carrier and homozygote frequencies across populations and continents derived from allele frequency under Hardy–Weinberg equilibrium. (F) IL-34 levels in CSF and serum stratified by sex, dementia status, amyloid status, and tau status. (G) Pearson correlations between IL-34 and CSF Alzheimer’s disease biomarkers (Aβ 42 , pTau181, and total tau), shown for all subjects and after stratification by Y213X carrier status and amyloid status. Error bars denote 95% confidence intervals. Asterisks indicate significance thresholds (∗ p < 0.01, ∗∗ p < 0.001).

Techniques Used: Derivative Assay

Box plots showing CSF IL-34 levels in individuals stratified by IL34 genotype (Y213/Y213, Y213/X, and X213/X213), measured across three independent experiments using two orthogonal proteomic platforms: two SomaScan assays (left and middle panels) and one Olink immunoassay (right panel). Across all platforms, carriers of the IL-34-Y213X variant show a marked reduction in CSF IL-34 levels. p values indicate statistical significance of genotype effects.
Figure Legend Snippet: Box plots showing CSF IL-34 levels in individuals stratified by IL34 genotype (Y213/Y213, Y213/X, and X213/X213), measured across three independent experiments using two orthogonal proteomic platforms: two SomaScan assays (left and middle panels) and one Olink immunoassay (right panel). Across all platforms, carriers of the IL-34-Y213X variant show a marked reduction in CSF IL-34 levels. p values indicate statistical significance of genotype effects.

Techniques Used: Variant Assay

(A) STRING protein–protein interaction network of proteins associated with CSF IL-34 levels, highlighting two major modules. (B) Gene Ontology enrichment results for the module positively associated with IL-34 (red network), showing enrichment for neuronal and synaptic biology. (C) Gene Ontology enrichment results for the module negatively associated with IL-34 (light orange network), enriched for cytokine-mediated signaling and related immune processes. Bubble size reflects gene counts and color reflects FDR-adjusted significance.
Figure Legend Snippet: (A) STRING protein–protein interaction network of proteins associated with CSF IL-34 levels, highlighting two major modules. (B) Gene Ontology enrichment results for the module positively associated with IL-34 (red network), showing enrichment for neuronal and synaptic biology. (C) Gene Ontology enrichment results for the module negatively associated with IL-34 (light orange network), enriched for cytokine-mediated signaling and related immune processes. Bubble size reflects gene counts and color reflects FDR-adjusted significance.

Techniques Used:

(A) Volcano plot comparing CSF proteomes from IL-34 Y213X homozygotes and matched controls, highlighting nominally significant proteins. (B) Heatmap summarizing effect sizes and statistical significance for the selected proteins shown in panel A. (C) Functional enrichment of pathways represented among proteins decreased in IL-34 homozygotes. (D) Functional enrichment of pathways represented among proteins increased in IL-34 homozygotes. Bubble size reflects gene counts and color denotes FDR-adjusted significance.
Figure Legend Snippet: (A) Volcano plot comparing CSF proteomes from IL-34 Y213X homozygotes and matched controls, highlighting nominally significant proteins. (B) Heatmap summarizing effect sizes and statistical significance for the selected proteins shown in panel A. (C) Functional enrichment of pathways represented among proteins decreased in IL-34 homozygotes. (D) Functional enrichment of pathways represented among proteins increased in IL-34 homozygotes. Bubble size reflects gene counts and color denotes FDR-adjusted significance.

Techniques Used: Functional Assay

AlphaFold-predicted structure of IL-34 indicating the position of the Y213 residue and the resulting Y213X truncation. The truncation localizes to the unstructured C-terminal region, distal from the folded core of the protein, suggesting that the overall globular structure is preserved and that major disruption of somamer- or antibody-binding epitopes is unlikely.
Figure Legend Snippet: AlphaFold-predicted structure of IL-34 indicating the position of the Y213 residue and the resulting Y213X truncation. The truncation localizes to the unstructured C-terminal region, distal from the folded core of the protein, suggesting that the overall globular structure is preserved and that major disruption of somamer- or antibody-binding epitopes is unlikely.

Techniques Used: Residue, Disruption, Binding Assay



Similar Products

86
Shanghai Model Organisms Center il 34 em2smoc
(A) <t>Standardized</t> <t>IL-34</t> levels measured in cerebrospinal fluid (CSF; SomaScan) across Y213X genotypes (WT/WT, WT/MUT, MUT/MUT). (B) Standardized IL-34 levels measured in serum (Olink) across Y213X genotypes. (C) Relationship between standardized IL-34 levels and age, shown for CSF (gray) and serum (red). (D) Correlation between serum and CSF IL-34 levels across all subjects. (E) Expected Y213X carrier and homozygote frequencies across populations and continents derived from allele frequency under Hardy–Weinberg equilibrium. (F) IL-34 levels in CSF and serum stratified by sex, dementia status, amyloid status, and tau status. (G) Pearson correlations between IL-34 and CSF Alzheimer’s disease biomarkers (Aβ 42 , pTau181, and total tau), shown for all subjects and after stratification by Y213X carrier status and amyloid status. Error bars denote 95% confidence intervals. Asterisks indicate significance thresholds (∗ p < 0.01, ∗∗ p < 0.001).
Il 34 Em2smoc, supplied by Shanghai Model Organisms Center, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+34+em2smoc/34+em2smoc+il/med_rxiv__64898__2026__02__21__26346696-261-21-23
Average 86 stars, based on 1 article reviews
il 34 em2smoc - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


(A) Standardized IL-34 levels measured in cerebrospinal fluid (CSF; SomaScan) across Y213X genotypes (WT/WT, WT/MUT, MUT/MUT). (B) Standardized IL-34 levels measured in serum (Olink) across Y213X genotypes. (C) Relationship between standardized IL-34 levels and age, shown for CSF (gray) and serum (red). (D) Correlation between serum and CSF IL-34 levels across all subjects. (E) Expected Y213X carrier and homozygote frequencies across populations and continents derived from allele frequency under Hardy–Weinberg equilibrium. (F) IL-34 levels in CSF and serum stratified by sex, dementia status, amyloid status, and tau status. (G) Pearson correlations between IL-34 and CSF Alzheimer’s disease biomarkers (Aβ 42 , pTau181, and total tau), shown for all subjects and after stratification by Y213X carrier status and amyloid status. Error bars denote 95% confidence intervals. Asterisks indicate significance thresholds (∗ p < 0.01, ∗∗ p < 0.001).

Journal: medRxiv

Article Title: Defining and Modeling Human Interleukin-34 Deficiency

doi: 10.64898/2026.02.21.26346696

Figure Lengend Snippet: (A) Standardized IL-34 levels measured in cerebrospinal fluid (CSF; SomaScan) across Y213X genotypes (WT/WT, WT/MUT, MUT/MUT). (B) Standardized IL-34 levels measured in serum (Olink) across Y213X genotypes. (C) Relationship between standardized IL-34 levels and age, shown for CSF (gray) and serum (red). (D) Correlation between serum and CSF IL-34 levels across all subjects. (E) Expected Y213X carrier and homozygote frequencies across populations and continents derived from allele frequency under Hardy–Weinberg equilibrium. (F) IL-34 levels in CSF and serum stratified by sex, dementia status, amyloid status, and tau status. (G) Pearson correlations between IL-34 and CSF Alzheimer’s disease biomarkers (Aβ 42 , pTau181, and total tau), shown for all subjects and after stratification by Y213X carrier status and amyloid status. Error bars denote 95% confidence intervals. Asterisks indicate significance thresholds (∗ p < 0.01, ∗∗ p < 0.001).

Article Snippet: Four mouse lines were used: APP swe , PSEN1 dE (APP/PS1) (The Jackson Laboratory, Bar Harbor, ME, USA, Stock No: 004462), IL-34 em2Smoc (Shanghai Model Organisms Center, Shanghai, China.

Techniques: Derivative Assay

Box plots showing CSF IL-34 levels in individuals stratified by IL34 genotype (Y213/Y213, Y213/X, and X213/X213), measured across three independent experiments using two orthogonal proteomic platforms: two SomaScan assays (left and middle panels) and one Olink immunoassay (right panel). Across all platforms, carriers of the IL-34-Y213X variant show a marked reduction in CSF IL-34 levels. p values indicate statistical significance of genotype effects.

Journal: medRxiv

Article Title: Defining and Modeling Human Interleukin-34 Deficiency

doi: 10.64898/2026.02.21.26346696

Figure Lengend Snippet: Box plots showing CSF IL-34 levels in individuals stratified by IL34 genotype (Y213/Y213, Y213/X, and X213/X213), measured across three independent experiments using two orthogonal proteomic platforms: two SomaScan assays (left and middle panels) and one Olink immunoassay (right panel). Across all platforms, carriers of the IL-34-Y213X variant show a marked reduction in CSF IL-34 levels. p values indicate statistical significance of genotype effects.

Article Snippet: Four mouse lines were used: APP swe , PSEN1 dE (APP/PS1) (The Jackson Laboratory, Bar Harbor, ME, USA, Stock No: 004462), IL-34 em2Smoc (Shanghai Model Organisms Center, Shanghai, China.

Techniques: Variant Assay

(A) STRING protein–protein interaction network of proteins associated with CSF IL-34 levels, highlighting two major modules. (B) Gene Ontology enrichment results for the module positively associated with IL-34 (red network), showing enrichment for neuronal and synaptic biology. (C) Gene Ontology enrichment results for the module negatively associated with IL-34 (light orange network), enriched for cytokine-mediated signaling and related immune processes. Bubble size reflects gene counts and color reflects FDR-adjusted significance.

Journal: medRxiv

Article Title: Defining and Modeling Human Interleukin-34 Deficiency

doi: 10.64898/2026.02.21.26346696

Figure Lengend Snippet: (A) STRING protein–protein interaction network of proteins associated with CSF IL-34 levels, highlighting two major modules. (B) Gene Ontology enrichment results for the module positively associated with IL-34 (red network), showing enrichment for neuronal and synaptic biology. (C) Gene Ontology enrichment results for the module negatively associated with IL-34 (light orange network), enriched for cytokine-mediated signaling and related immune processes. Bubble size reflects gene counts and color reflects FDR-adjusted significance.

Article Snippet: Four mouse lines were used: APP swe , PSEN1 dE (APP/PS1) (The Jackson Laboratory, Bar Harbor, ME, USA, Stock No: 004462), IL-34 em2Smoc (Shanghai Model Organisms Center, Shanghai, China.

Techniques:

(A) Volcano plot comparing CSF proteomes from IL-34 Y213X homozygotes and matched controls, highlighting nominally significant proteins. (B) Heatmap summarizing effect sizes and statistical significance for the selected proteins shown in panel A. (C) Functional enrichment of pathways represented among proteins decreased in IL-34 homozygotes. (D) Functional enrichment of pathways represented among proteins increased in IL-34 homozygotes. Bubble size reflects gene counts and color denotes FDR-adjusted significance.

Journal: medRxiv

Article Title: Defining and Modeling Human Interleukin-34 Deficiency

doi: 10.64898/2026.02.21.26346696

Figure Lengend Snippet: (A) Volcano plot comparing CSF proteomes from IL-34 Y213X homozygotes and matched controls, highlighting nominally significant proteins. (B) Heatmap summarizing effect sizes and statistical significance for the selected proteins shown in panel A. (C) Functional enrichment of pathways represented among proteins decreased in IL-34 homozygotes. (D) Functional enrichment of pathways represented among proteins increased in IL-34 homozygotes. Bubble size reflects gene counts and color denotes FDR-adjusted significance.

Article Snippet: Four mouse lines were used: APP swe , PSEN1 dE (APP/PS1) (The Jackson Laboratory, Bar Harbor, ME, USA, Stock No: 004462), IL-34 em2Smoc (Shanghai Model Organisms Center, Shanghai, China.

Techniques: Functional Assay

AlphaFold-predicted structure of IL-34 indicating the position of the Y213 residue and the resulting Y213X truncation. The truncation localizes to the unstructured C-terminal region, distal from the folded core of the protein, suggesting that the overall globular structure is preserved and that major disruption of somamer- or antibody-binding epitopes is unlikely.

Journal: medRxiv

Article Title: Defining and Modeling Human Interleukin-34 Deficiency

doi: 10.64898/2026.02.21.26346696

Figure Lengend Snippet: AlphaFold-predicted structure of IL-34 indicating the position of the Y213 residue and the resulting Y213X truncation. The truncation localizes to the unstructured C-terminal region, distal from the folded core of the protein, suggesting that the overall globular structure is preserved and that major disruption of somamer- or antibody-binding epitopes is unlikely.

Article Snippet: Four mouse lines were used: APP swe , PSEN1 dE (APP/PS1) (The Jackson Laboratory, Bar Harbor, ME, USA, Stock No: 004462), IL-34 em2Smoc (Shanghai Model Organisms Center, Shanghai, China.

Techniques: Residue, Disruption, Binding Assay